M&A / Deals Asahi Kasei acquires German company Aicuris Pharmaceutical TechnologyAsahi Kasei has completed its acquisition of Aicuris Anti-infective Cures, a German biopharmaceutical company.M&A / DealsRead full story pharminent April 21, 2026 (Last updated: April 21, 2026) Pharmaceutical Technology Asahi Kasei has completed its acquisition of Aicuris Anti-infective Cures, a German biopharmaceutical company. M&A / DealsRead full story Post navigation Previous: Trump executive order lifts psychedelics biotechsNext: Italy leads the way on child genetic disease diagnosis Related Stories M&A / Deals BioMarin spends up to $490m for Alesta’s bone disease candidate pharminent August 19, 2026 M&A / Deals J&J hands lymphoma bispecific CAR T back to AbelZeta pharminent August 17, 2026 M&A / Deals Novo Nordisk and AWS form AI partnership to speed drug discovery pharminent August 17, 2026
